12 Patients using this GLP-1 agonist should be counseled to see their eyecare provider immediately if they experience sudden loss of vision
They manage blood sugar and stabilise hunger to treat obesity and type 2 diabetes
Yi B, Hu X, Wen Z, Zhang T, Cai Y
Ro (formerly Roman), is an online telehealth platform launched in 2017 that gives patients access to two FDA-approved GLP-1 medications, Wegovy and Zepbound, as part of its weight-loss program, the Body Program
While each peptide has been studied individually, combining them introduces new variables that require careful scrutiny
But so many athletes and fitness-focused people are now taking the drugs, to the extent that use is outpacing clinical guidance